December 17, 2014 8:44 PM ET

Biotechnology

Company Overview of Adaptive Therapeutics, Inc.

Key Executives for Adaptive Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Max Ladjevardi 11 RelationshipsFounder, President, Chief Operating Officer and Director--
M. Reza Ghadiri Ph.D. 31 RelationshipsFounder and Chairman of Scientific Advisory Board--
Muzammil M. Mansuri Ph.D.28 RelationshipsExecutive Chairman--
Daniel L. Kisner M.D.76 RelationshipsConsultant and Director67

Adaptive Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Muzammil M. Mansuri Ph.D. 28 RelationshipsAdaptive Therapeutics, Inc.--
Max Ladjevardi 11 RelationshipsAdaptive Therapeutics, Inc.--
M. Reza Ghadiri Ph.D. 31 RelationshipsAdaptive Therapeutics, Inc.--
Daniel L. Kisner M.D. 76 RelationshipsAdaptive Therapeutics, Inc.67
John W. Kozarich Ph.D. 50 RelationshipsActivX Biosciences, Inc.65
View All Board Members

Adaptive Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Ph.D. M. Reza Ghadiri31 Relationships8 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
361.9K
Bonus
206.4K
Total Short Term Compensation
436.2K
Total Value of Options
21.4M
Compensation as of Fiscal Year
Adaptive Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Hipolin Limited Announces Change of Directors
December 10, 2014 9:48 AM ET
Carewell Industries Limited Announces Executive Changes
December 08, 2014 3:47 AM ET
The Sun Products Corporation Appoints David R. White to its Board of Directors
December 04, 2014 11:30 AM ET
Reckitt Benckiser Group plc Announces Executive Changes
December 01, 2014 2:07 PM ET
Harbinger Group Inc. Announces Management Changes
November 25, 2014 2:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Adaptive Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.